According to the announcement, as a subsidiary of Jingdong group, Jingdong group plans to spin off Jingdong health to be listed on the main board of the stock exchange of Hong Kong. The completion time of the split listing will depend on factors such as market conditions. < / P > < p > according to public data, in May 2019, JD health obtained more than US $1 billion of round a financing, and separated and operated independently from Jingdong group. In August 2020, Jingdong health once again obtained the b-round financing of more than $830 million from Hillhead capital. < / P > < p > JD health is positioned as a “health management platform with supply chain as the core, medical services as the starting point, and digital driven user life cycle and full scene”. Its main business includes pharmaceutical retail and internet medical services, forming a closed-loop mode of “medicine + medicine” of JD health. Pharmaceutical retail includes self-service and platform mode, including B2B and B2C business, with various forms of performance including o2o; internet medical mainly focuses on the needs of patients, and carries out medical services such as online registration and online consultation. At present, Jingdong health has built core products and sub brands such as Jingdong pharmacy, Jingdong Internet hospital, smart hospital and Jingdong home medicine. Global Tech